Fenofibrate

• Lowers triglycerides, raises HDL-cholesterol and decreases concentrations of small LDL-cholesterol particles and apolipoprotein B, thus reducing the risk of cardiovascular diseases.

Atorvastatin

• Inhibits cholesterol synthesis, enhancing the efficacy of plasma exchange resulting in a decreased rate of production of low-density lipoprotein.
• More effective than policosanol in reducing LDL showing reduction by more than 41%.

Combination

• Safely exerts beneficial effects on endothelial function in patients with combined hyperlipidemia.